{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fidpodcast.simplecast.com%2Fepisodes%2Fcovid-19-oral-antivirals-mHQqfMxJ","width":444,"version":"1.0","type":"rich","title":"COVID-19 Oral Antiviral Agents","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/165defb8-f7d7-44fe-a7eb-a59f2c35d334/6c369911-fa00-4101-8734-7ce2c2c2e29d/covid-19-rc-3-0mm-podcasticon-antivirals.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/af8107c4-fb5c-428d-8bd5-a1e5dbc2bbc2\" height=\"200\" width=\"100%\" title=\"COVID-19 Oral Antiviral Agents\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Oral antiviral agents offer a new treatment option for nonhospitalized adult patients with COVID-19. Hear expert faculty discuss the safety and efficacy data of molnupiravir and nirmatrelvir (PF-07321332) plus ritonavir in outpatient adults with mild to moderate COVID-19."}